BioStem Technologies, Inc. (BSEM)
BioStem Technologies Market Cap : 79.42M for April 28, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 40.62M |
| Iovance Biotherapeutics, Inc. | 1.394B |
| Protokinetix, Inc. | 2.114M |
| GB Sciences, Inc. | 0.1221M |
| Travere Therapeutics, Inc. | 3.772B |
Market Cap Related Metrics
| PS Ratio | 0.6880 |
| Price to Book Value | 2.029 |
| Price to Free Cash Flow | 14.87 |
| Price | 4.72 |
| Earnings Yield | -10.60% |